Baird Financial Group, Inc. Royalty Pharma PLC Transaction History

Baird Financial Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $165,182 - $184,940	-4,142 Reduced 2.12%	190,791 $7.67 Million
Q2 2022 Aug 08, 2022	SELL	$37.53 - $44.22 $168,885 - $198,990	-4,500 Reduced 2.26%	194,933 $8.2 Million
Q1 2022 May 13, 2022	SELL	$37.46 - $42.44 $585,312 - $663,125	-15,625 Reduced 7.27%	199,433 $7.77 Million
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $7.77 Million - $9.08 Million	215,058 New	215,058 $7.77 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Baird Financial Group, Inc. with notifications on news.